CatalystMacro

LIMINATUS PHARMA REGAINS NASDAQ COMPLIANCE - SEEKINGALPHA

Liminatus Pharma regaining Nasdaq compliance removes delisting risk.

What changed

Liminatus Pharma regaining Nasdaq compliance removes delisting risk.

Why it matters

Liminatus Pharma regaining Nasdaq compliance removes delisting risk. — impact context not separately stored; see What changed.

Sources